The Emergency Use Authorization of Pharmaceuticals History and Utility During the COVID-19 Pandemic
Tran, A. and Witek, T.
(2021).
The Emergency Use Authorization of Pharmaceuticals: History and Utility During the COVID-19 Pandemic.
Pharmaceutical Medicine. 35(4): 203-213.
The authors examined the history of emergency use authorizations (EUAs) since their inception in 2004, with a particular focus on their use during the COVID-19 pandemic. EUAs facilitated the rollout of COVID-19 vaccines and allowed a pause for safety review of one vaccine. The authors also discussed new drug/vaccine application approvals.
Favorite:
Login to rate, favorite, and comments
on the article
Comments
0
Toggle Open/Close
You must Login to add a comment
- This item doesn't have any comments